CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Iris BioTechnologies Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Iris BioTechnologies Inc.
5201 Great America Parkway
Suite 320
Phone: (408) 867-2885p:408 867-2885 Santa Clara, CA  95054-1140  United States Fax: (408) 867-5068f:408 867-5068

This company is no longer actively traded on any major stock exchange.

Business Summary
Iris Biotechnologies Inc. (Iris) is a life sciences company. Iris focuses on precision medicine. The Company has developed a technology platform to determine an approach to cancer diagnosis and treatment. The Company's efforts are principally devoted to developing solutions for the detection and monitoring of monogenic and complex genomic diseases. The Company is in preparation for the launch of multiple products and services-based upon its Nano-biochip and BioWindows Medical Informatics System. Its Nano-Biochip product pipeline includes CancerChip, PrenatalChip, NeuroChip (Alzheimer's and Parkinson diseases), MetabolicChip (Diabetes), CardioChip, BloodChip and Chips for veterinary, agricultural (biofuel development), environmental, and other applications. Its BioWindows artificial intelligence system provides big data and analysis for clinical applications, drug development and stem cell research. Iris Wellness Labs, Inc. is the subsidiary of the Company.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201612/31/2015YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer Simon S.Chin 56 3/1/2007 2/1/1999
Chief Scientific Officer PaulYaswen 58 10/27/2013 10/27/2013
Vice President - Operations JamesLeBlanc 69 5/8/2009 5/8/2009
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Iris Biotechnologies Inc.
IRSB

General Information
Number of Employees: 5 (As of 9/30/2013)
Outstanding Shares: 21,368,011 (As of 11/14/2016)
Shareholders: 150
Stock Exchange: OTC
Federal Tax Id: 770506396
Fax Number: (408) 867-5068


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023